In this study, a high expression of nuclear N-cadherin predicted a poorer survival in patients with late stage disease, and multivariate analysis showed nuclear N-cadherin to be an independent prognostic marker for NPC patients. Here, CDH2 is linked to nasopharyngeal carcinoma.